<p>Gabriel S. Morris, Chief Financial Officer and Director of Immix Biopharma Inc., reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immix Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027107), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

IMMX

<p>Gabriel S. Morris, CFO and Director of Immix Biopharma Inc., reported acquiring common shares of the company. The information was published via EDGAR by the U.S. SEC on December 10, 2025. This news brief was generated by Public Technologies using AI and is for informational purposes only.</p>

Immix Biopharma CFO Gabriel S. Morris Reports Acquisition of Common Shares